151 related articles for article (PubMed ID: 26131815)
21. Antiplatelet drugs are a risk factor for esophageal mucosal injury.
Sugimoto M; Uotani T; Nishino M; Yamade M; Sahara S; Yamada T; Osawa S; Sugimoto K; Umemura K; Watanabe H; Miyajima H; Furuta T
Digestion; 2013; 87(4):281-9. PubMed ID: 23774797
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Iijima K; Shimosegawa T
Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
[TBL] [Abstract][Full Text] [Related]
23. [Gastroduodenal mucosal injuries by aspirine. Management of the risks].
MartÃnez M JD; Molano V JC; Henao R SC
Rev Gastroenterol Peru; 2016; 36(2):129-34. PubMed ID: 27409089
[TBL] [Abstract][Full Text] [Related]
24. Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury.
Wu Y; Hu Y; You P; Chi YJ; Zhou JH; Zhang YY; Liu YL
Chin Med J (Engl); 2016 Jan; 129(2):174-80. PubMed ID: 26830988
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
26. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
[TBL] [Abstract][Full Text] [Related]
27. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
28. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
[TBL] [Abstract][Full Text] [Related]
29. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
Bretagne JF
Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
[TBL] [Abstract][Full Text] [Related]
30. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
31. Increased susceptibility of aging gastric mucosa to injury and delayed healing: Clinical implications.
Tarnawski AS; Ahluwalia A
World J Gastroenterol; 2018 Nov; 24(42):4721-4727. PubMed ID: 30479459
[TBL] [Abstract][Full Text] [Related]
32. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.
Sugisaki N; Iwakiri R; Tsuruoka N; Sakata Y; Shimoda R; Fujimoto S; Eguchi Y; Fujimoto K
J Gastroenterol; 2018 Dec; 53(12):1253-1260. PubMed ID: 29948304
[TBL] [Abstract][Full Text] [Related]
33. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy.
Harada H; Suehiro S; Murakami D; Nakahara R; Nagasaka T; Ujihara T; Sagami R; Katsuyama Y; Hayasaka K; Amano Y
World J Gastroenterol; 2019 Jan; 25(4):457-468. PubMed ID: 30700942
[TBL] [Abstract][Full Text] [Related]
35. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.
Dammann HG; Burkhardt F; Wolf N
Aliment Pharmacol Ther; 1999 Aug; 13(8):1109-14. PubMed ID: 10468689
[TBL] [Abstract][Full Text] [Related]
36. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H
J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523
[TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Schalekamp T; Klungel OH; Souverein PC; de Boer A
Thromb Haemost; 2008 Dec; 100(6):1076-83. PubMed ID: 19132233
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
Kobata Y; Yajima H; Yamao J; Tanaka Y; Fukui H; Takakura Y
Mod Rheumatol; 2009; 19(6):629-36. PubMed ID: 19728013
[TBL] [Abstract][Full Text] [Related]
40. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
